301 related articles for article (PubMed ID: 17220275)
1. The hypoxia-inducible factor 2alpha N-terminal and C-terminal transactivation domains cooperate to promote renal tumorigenesis in vivo.
Yan Q; Bartz S; Mao M; Li L; Kaelin WG
Mol Cell Biol; 2007 Mar; 27(6):2092-102. PubMed ID: 17220275
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of hypoxia-inducible factor 2alpha in renal cell carcinoma associated with loss of Tsc-2 tumor suppressor gene.
Liu MY; Poellinger L; Walker CL
Cancer Res; 2003 May; 63(10):2675-80. PubMed ID: 12750296
[TBL] [Abstract][Full Text] [Related]
3. Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch.
Lando D; Peet DJ; Whelan DA; Gorman JJ; Whitelaw ML
Science; 2002 Feb; 295(5556):858-61. PubMed ID: 11823643
[TBL] [Abstract][Full Text] [Related]
4. Targeted inactivation of fh1 causes proliferative renal cyst development and activation of the hypoxia pathway.
Pollard PJ; Spencer-Dene B; Shukla D; Howarth K; Nye E; El-Bahrawy M; Deheragoda M; Joannou M; McDonald S; Martin A; Igarashi P; Varsani-Brown S; Rosewell I; Poulsom R; Maxwell P; Stamp GW; Tomlinson IP
Cancer Cell; 2007 Apr; 11(4):311-9. PubMed ID: 17418408
[TBL] [Abstract][Full Text] [Related]
5. Failure to prolyl hydroxylate hypoxia-inducible factor alpha phenocopies VHL inactivation in vivo.
Kim WY; Safran M; Buckley MR; Ebert BL; Glickman J; Bosenberg M; Regan M; Kaelin WG
EMBO J; 2006 Oct; 25(19):4650-62. PubMed ID: 16977322
[TBL] [Abstract][Full Text] [Related]
6. Clinical implications of hypoxia inducible factor in renal cell carcinoma.
Smaldone MC; Maranchie JK
Urol Oncol; 2009; 27(3):238-45. PubMed ID: 19414111
[TBL] [Abstract][Full Text] [Related]
7. Erythrocytosis-associated HIF-2alpha mutations demonstrate a critical role for residues C-terminal to the hydroxylacceptor proline.
Furlow PW; Percy MJ; Sutherland S; Bierl C; McMullin MF; Master SR; Lappin TR; Lee FS
J Biol Chem; 2009 Apr; 284(14):9050-8. PubMed ID: 19208626
[TBL] [Abstract][Full Text] [Related]
8. Dysregulated D-dopachrome tautomerase, a hypoxia-inducible factor-dependent gene, cooperates with macrophage migration inhibitory factor in renal tumorigenesis.
Pasupuleti V; Du W; Gupta Y; Yeh IJ; Montano M; Magi-Galuzzi C; Welford SM
J Biol Chem; 2014 Feb; 289(6):3713-23. PubMed ID: 24356968
[TBL] [Abstract][Full Text] [Related]
9. Int6/eIF3e silencing promotes functional blood vessel outgrowth and enhances wound healing by upregulating hypoxia-induced factor 2alpha expression.
Chen L; Endler A; Uchida K; Horiguchi S; Morizane Y; Iijima O; Toi M; Shibasaki F
Circulation; 2010 Aug; 122(9):910-9. PubMed ID: 20713899
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-inducible factor prolyl-hydroxylase: purification and assays of PHD2.
Hewitson KS; Schofield CJ; Ratcliffe PJ
Methods Enzymol; 2007; 435():25-42. PubMed ID: 17998047
[TBL] [Abstract][Full Text] [Related]
11. A MALAT1/HIF-2α feedback loop contributes to arsenite carcinogenesis.
Luo F; Sun B; Li H; Xu Y; Liu Y; Liu X; Lu L; Li J; Wang Q; Wei S; Shi L; Lu X; Liu Q; Zhang A
Oncotarget; 2016 Feb; 7(5):5769-87. PubMed ID: 26735578
[TBL] [Abstract][Full Text] [Related]
12. Onconeuronal cerebellar degeneration-related antigen, Cdr2, is strongly expressed in papillary renal cell carcinoma and leads to attenuated hypoxic response.
Balamurugan K; Luu VD; Kaufmann MR; Hofmann VS; Boysen G; Barth S; Bordoli MR; Stiehl DP; Moch H; Schraml P; Wenger RH; Camenisch G
Oncogene; 2009 Sep; 28(37):3274-85. PubMed ID: 19581925
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-inducible factor-1alpha and -2alpha additively promote endothelial vasculogenic properties.
Ben-Shoshan J; Maysel-Auslender S; Luboshits G; Barshack I; Polak-Charcon S; Tzahor E; Keren G; George J
J Vasc Res; 2009; 46(4):299-310. PubMed ID: 19077391
[TBL] [Abstract][Full Text] [Related]
14. Sprouty2 Protein Regulates Hypoxia-inducible Factor-α (HIFα) Protein Levels and Transcription of HIFα-responsive Genes.
Hicks KC; Patel TB
J Biol Chem; 2016 Aug; 291(32):16787-801. PubMed ID: 27281823
[TBL] [Abstract][Full Text] [Related]
15. CCAAT/enhancer-binding protein alpha antagonizes transcriptional activity of hypoxia-inducible factor 1 alpha with direct protein-protein interaction.
Yang L; Jiang Y; Wu SF; Zhou MY; Wu YL; Chen GQ
Carcinogenesis; 2008 Feb; 29(2):291-8. PubMed ID: 18024476
[TBL] [Abstract][Full Text] [Related]
16. Homology modeling and molecular dynamics simulation of the HIF2α degradation-related HIF2α-VHL complex.
Dong X; Su X; Yu J; Liu J; Shi X; Pan Q; Yang J; Chen J; Li L; Cao H
J Mol Graph Model; 2017 Jan; 71():116-123. PubMed ID: 27902963
[TBL] [Abstract][Full Text] [Related]
17. Transgenic models to understand hypoxia-inducible factor function.
Doedens A; Johnson RS
Methods Enzymol; 2007; 435():87-105. PubMed ID: 17998050
[TBL] [Abstract][Full Text] [Related]
18. The hypoxia-inducible factor-2alpha is stabilized by oxidative stress involving NOX4.
Diebold I; Flügel D; Becht S; Belaiba RS; Bonello S; Hess J; Kietzmann T; Görlach A
Antioxid Redox Signal; 2010 Aug; 13(4):425-36. PubMed ID: 20039838
[TBL] [Abstract][Full Text] [Related]
19. The von Hippel-Lindau protein, HIF hydroxylation, and oxygen sensing.
Kaelin WG
Biochem Biophys Res Commun; 2005 Dec; 338(1):627-38. PubMed ID: 16153592
[TBL] [Abstract][Full Text] [Related]
20. Autophagy mediates HIF2α degradation and suppresses renal tumorigenesis.
Liu XD; Yao J; Tripathi DN; Ding Z; Xu Y; Sun M; Zhang J; Bai S; German P; Hoang A; Zhou L; Jonasch D; Zhang X; Conti CJ; Efstathiou E; Tannir NM; Eissa NT; Mills GB; Walker CL; Jonasch E
Oncogene; 2015 May; 34(19):2450-60. PubMed ID: 24998849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]